Latest Market News

Rhythm Biosciences reported a strong December quarter, securing a $3.2 million R&D tax incentive and completing a strategic acquisition of Genetype assets, positioning the company for commercial expansion in cancer diagnostics.

Golden Horse Minerals has swiftly completed its inaugural drilling campaign at Hakes Find shortly after its ASX debut, setting the stage for an active exploration year in 2025.

Great Divide Mining has completed due diligence on the Adelong Gold Project, clearing the way to acquire a 15% stake and take operational control. The company aims to swiftly restart production at the historic mine.

BPH Global has completed its acquisition of Indonesian seaweed assets, establishing a wholly owned subsidiary and launching joint operations aimed at expanding seaweed cultivation and bio-stimulant product development across Asia.

Nova Minerals has reported remarkable high-grade gold and gallium discoveries at its Wombat prospect within the Estelle Project, reinforcing the site's potential for significant mineral wealth and future drilling campaigns.

Regal Investment Fund has updated its dividend announcement, confirming an actual ordinary dividend of AUD 0.10 per unit payable in March 2025. The distribution relates to the six-month period ending December 31, 2024.

EZZ Life Science Holdings delivered a robust Q2 FY25 with a 16.6% increase in customer receipts and a 308% jump in operating cash flows, while gearing up for US market entry and expanding its global footprint.

Powerhouse Ventures Limited reports a robust quarterly performance with a notable uplift in net tangible assets to 10.4 cents per share, driven by strategic acquisitions and active investment management.

Imricor Medical Systems reports strong Q4 CY24 progress with successful FDA review, CE Mark submissions, and an 840% jump in consumables revenue, positioning the company for expanded global market penetration.

Tinybeans Group Limited reported a 9% increase in quarterly subscription revenue to US$0.80 million in Q2 FY25, alongside a significant reduction in cash burn and operational expenses following a major restructure.

Orpheus Uranium Limited reports a productive December quarter marked by a successful $1.66 million capital raise, completion of a major gravity survey at Mount Douglas, and ongoing progress toward regulatory approvals for advanced uranium exploration.

The Calmer Co. International Limited has reported a remarkable surge in sales and cash receipts for the first half of FY25, exceeding the entire FY24 sales. Alongside a strategic CEO transition and factory upgrade, the company is sharpening its focus on profitable growth and cost control.